TransCode Therapeutics Acquires Polynoma and Secures $25M Funding to Advance Cancer Treatments

TransCode Therapeutics acquires Polynoma LLC and receives $25M investment from CK Life Sciences to develop innovative cancer therapies, including melanoma vaccine and microRNA treatments.